NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions - Aix-Marseille Université Access content directly
Journal Articles Cell Reports Year : 2021

NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

Matteo Simonelli
Federico Colombo

Abstract

Human Vδ2 cells are innate-like γδ T effectors performing potent immune surveillance against tumors. The constitutive expression of NKG2A identifies a subset of Vδ2 T cells licensed with an intrinsic hyper-responsiveness against cancer. Indeed, the transcriptomic profiles of NKG2A+ and NKG2A- cells characterize two distinct "intralineages" of Vδ2 T lymphocytes that appear early during development, keep their phenotypes, and show self-renewal capabilities in adult life. The hyper-responsiveness of NKG2A+ Vδ2 T cells is counterbalanced by the inhibitory signaling delivered by human leukocyte antigen E (HLA-E) expressed on malignant cells as a tumor-escape mechanism. However, either masking or knocking out NKG2A restores the capacity of Vδ2 T cells to exert the highest effector functions even against HLA-E+ tumors. This is highly relevant in the clinic, as the different degrees of engagement of the NKG2A-HLA-E checkpoint in hepatocellular carcinoma, glioblastoma, and non-small cell lung cancer directly impact patients' overall survival. These findings open avenues for developing combined cellular and immunologic anticancer therapies.

Dates and versions

hal-03566006 , version 1 (11-02-2022)

Identifiers

Cite

Valentina Cazzetta, Elena Bruni, Sara Terzoli, Claudia Carenza, Sara Franzese, et al.. NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions. Cell Reports, 2021, 37 (3), pp.109871. ⟨10.1016/j.celrep.2021.109871⟩. ⟨hal-03566006⟩
15 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More